Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 406992
Gene Symbol: MIR210
MIR210
0.010 AlteredExpression disease BEFREE By contrast, no changes in miR-92a-3p, miR-181c-5p or miR-210-3p levels were observed in plasma obtained from a cohort of FTD. 31092279 2019
Entrez Id: 9075
Gene Symbol: CLDN2
CLDN2
0.010 Biomarker disease BEFREE Clinical consensus criteria that take into account a full neuropsychological examination have relatively good accuracy (sensitivity [se] 75-95%, specificity [sp] 82-95%) to diagnose FTD, although misdiagnosis (mostly AD) is common. 31447625 2019
Entrez Id: 2066
Gene Symbol: ERBB4
ERBB4
0.010 AlteredExpression disease BEFREE Ecto-ErbB4 levels were decreased in CSF from ALS patients (n = 20) and ALS with concomitant frontotemporal dementia patients (n = 10), compared to age-matched controls (n = 13). 30594809 2019
Entrez Id: 56242
Gene Symbol: ZNF253
ZNF253
0.010 Biomarker disease BEFREE TDP-43 (transactive- response DNA binding protein) amazes structural biologist as its aberrant ubiquitinated cytosolic inclusions is largely involved in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). 30315897 2019
Entrez Id: 1804
Gene Symbol: DPP6
DPP6
0.010 GeneticVariation disease BEFREE DPP6 resequencing identified significantly more rare variants-nonsense, frameshift, and missense-in early-onset Alzheimer's disease (EOAD, p value = 0.03, OR = 2.21 95% CI 1.05-4.82) and frontotemporal dementia (FTD, p = 0.006, OR = 2.59, 95% CI 1.28-5.49) patient cohorts. 30874922 2019
Entrez Id: 3665
Gene Symbol: IRF7
IRF7
0.010 GeneticVariation disease BEFREE Through inspection of our whole-genome sequence data for genes with an excess of rare loss-of-function variants in FTLD-TDP patients (n ≥ 3) as compared to controls (n = 0), we further discovered a possible role for genes functioning within the TBK1-related immune pathway (e.g., DHX58, TRIM21, IRF7) in the genetic etiology of FTLD-TDP. 30739198 2019
Entrez Id: 1654
Gene Symbol: DDX3X
DDX3X
0.010 AlteredExpression disease BEFREE Reduction of DDX3X increases DPR levels in C9ORF72-ALS/FTD patient cells and enhances (GGGGCC)n-mediated toxicity in Drosophila. 31587919 2019
Entrez Id: 6230
Gene Symbol: RPS25
RPS25
0.010 Biomarker disease BEFREE We performed a genetic screen for regulators of RAN translation and identified small ribosomal protein subunit 25 (RPS25), presenting a potential therapeutic target for C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia and other neurodegenerative diseases caused by nucleotide repeat expansions. 31358992 2019
Entrez Id: 4852
Gene Symbol: NPY
NPY
0.010 AlteredExpression disease BEFREE Compared to controls, ALS and ALS-cognitive had higher NPY levels and bvFTD had lower NPY levels, while leptin levels were increased in all patient groups. 30911572 2019
Entrez Id: 347
Gene Symbol: APOD
APOD
0.010 Biomarker disease BEFREE Apolipoprotein D Upregulation in Alzheimer's Disease but Not Frontotemporal Dementia. 30467822 2019
Entrez Id: 406957
Gene Symbol: MIR181C
MIR181C
0.010 AlteredExpression disease BEFREE By contrast, no changes in miR-92a-3p, miR-181c-5p or miR-210-3p levels were observed in plasma obtained from a cohort of FTD. 31092279 2019
Entrez Id: 57154
Gene Symbol: SMURF1
SMURF1
0.010 Biomarker disease BEFREE Our study showed that valosin-containing protein/p97, the mutations of which lead to rare forms of Paget's disease of bone (PDB)-like syndrome-such as inclusion body myopathy (IBM) associated with Paget's disease of bone and frontotemporal dementia (IBM-PFD)-together with its adaptor nuclear protein localization (NPL)4, specifically interact with Smurf1 and deliver the ubiquitinated Smurf1 for degradation. 30335548 2019
Entrez Id: 5697
Gene Symbol: PYY
PYY
0.010 GeneticVariation disease BEFREE One hundred and twenty-seven participants (36 ALS, 26 ALS- cognitive, patients with additional cognitive behavioral features, and 35 behavioral variant FTD (bvFTD) and 30 controls) underwent fasting blood analyses of leptin, ghrelin, neuropeptide Y (NPY), peptide YY (PYY), and insulin levels. 30911572 2019
Entrez Id: 2481
Gene Symbol: FRAXE
FRAXE
0.010 AlteredExpression disease BEFREE Transcription elongation factor AFF2/FMR2 regulates expression of expanded GGGGCC repeat-containing C9ORF72 allele in ALS/FTD. 31784536 2019
Entrez Id: 406989
Gene Symbol: MIR206
MIR206
0.010 Biomarker disease BEFREE After a global miRNA profiling, significant downregulation of miR-663a, miR-502-3p, and miR-206 (p = 0.0001, p = 0.0002, and p = 0.02 respectively) in FTD patients was confirmed when compared with HCs in a larger case-control sample. 30826067 2019
Entrez Id: 387522
Gene Symbol: TMEM189-UBE2V1
TMEM189-UBE2V1
0.010 Biomarker disease BEFREE TDP-43 (transactive- response DNA binding protein) amazes structural biologist as its aberrant ubiquitinated cytosolic inclusions is largely involved in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). 30315897 2019
Entrez Id: 79643
Gene Symbol: CHMP6
CHMP6
0.010 GeneticVariation disease BEFREE Our screens uncovered that knockdown of several components of the endosomal sorting complexes required for transport (ESCRT) machinery, including charged multivesicular body protein 6 (CHMP6), or CHMP2A in combination with CHMP2B (whose gene is linked to familial FTD), promote propagation of tau aggregation. 31578281 2019
Entrez Id: 5903
Gene Symbol: RANBP2
RANBP2
0.010 GeneticVariation disease BEFREE Presence of tau astrogliopathy in frontotemporal dementia caused by a novel Grn nonsense (Trp2*) mutation. 30545478 2019
Entrez Id: 10241
Gene Symbol: CALCOCO2
CALCOCO2
0.010 Biomarker disease BEFREE Abbreviations: AAV: adeno-associated virus; AD: Alzheimer disease; ALP: autophagy-lysosomal pathway; ALS: amyotrophic lateral sclerosis; CALCOCO2/NDP52: calcium binding and coiled-coil domain 2; FTD: frontotemporal dementias; HD: Huntington disease; HTT: huntingtin; LIR: LC3-interacting region; NBR1: autophagy cargo receptor; NFE2L2/Nrf2: nuclear factor, erythroid derived 2, like 2; NFTs: neurofibrillary tangles; MAPT: microtubule associated protein tau; OPTN: optineurin; p-MAPT: hyperphosphorylated MAPT; PFA: paraformaldehyde; TARDBP/TDP-43: TAR DNA binding protein; TAX1BP1 Tax1: binding protein 1; ThioS: thioflavin-S; UBA: ubiquitin-associated. 30290707 2019
Entrez Id: 26013
Gene Symbol: L3MBTL1
L3MBTL1
0.010 Biomarker disease BEFREE Both L3MBTL1 and SET domain-containing protein 8 were upregulated in the central nervous systems of mouse models of amyotrophic lateral sclerosis and human patients with amyotrophic lateral sclerosis/frontotemporal dementia. 31061493 2019
Entrez Id: 10189
Gene Symbol: ALYREF
ALYREF
0.010 Biomarker disease BEFREE These data support ALYREF as a contributor to ALS/FTD and highlight its downregulation as a potential therapeutic target that may affect co-existing disease etiologies. 31036086 2019
Entrez Id: 256471
Gene Symbol: MFSD8
MFSD8
0.010 GeneticVariation disease BEFREE Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia. 30382371 2019
Entrez Id: 7003
Gene Symbol: TEAD1
TEAD1
0.010 AlteredExpression disease BEFREE Drosophila Ref1/ALYREF regulates transcription and toxicity associated with ALS/FTD disease etiologies. 31036086 2019
Entrez Id: 7335
Gene Symbol: UBE2V1
UBE2V1
0.010 Biomarker disease BEFREE TDP-43 (transactive- response DNA binding protein) amazes structural biologist as its aberrant ubiquitinated cytosolic inclusions is largely involved in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). 30315897 2019
Entrez Id: 1118
Gene Symbol: CHIT1
CHIT1
0.010 Biomarker disease BEFREE In gFTD (n=23), increased YKL-40 and GFAP were observed (p<0.05), whereas CHIT1 was nearly not affected. 30224549 2019